Clinical Trials Logo

Filter by:
NCT ID: NCT06406413 Recruiting - Clinical trials for Consciousness Disorders

Micro-movements in Patients With Prolonged Disorders of Consciousness

Start date: May 1, 2024
Phase:
Study type: Observational

The goal of this observational study is to learn about the micro-movements in patients with prolonged disorders of consciousness. The main questions it aims to answer are: Use the neuropsychological paradigm model to monitor micro-movements, assess the patient's remaining level of consciousness and accurately classify it; screen out patients with cognitive-motor dissociation to improve the prognosis of cognitive function; explore the remaining brain function of patients with chronic disorders of consciousness and promote relevant study of neural mechanisms. Participants will be subjected to consciousness assessment by CRS-r scale, and their micro-movement changes in response to various emotional stimuli will be captured, along with the collection of EEG and MRI data. Follow-up evaluations will be conducted using the CRS-R scale and GOS scale, with a follow-up period of 6 months.

NCT ID: NCT06406244 Recruiting - Liver Cancer Clinical Trials

Efficacy of TEAS on Chronic Pain and Survival in Patients Undergoing Hepatectomy

Start date: April 20, 2024
Phase: N/A
Study type: Interventional

This study is a further observation and follow-up of the patients enrolled in the registration number NCT06341270 to further evaluate the efficacy of TEAS on postoperative chronic pain, quality of life and survival rate in patients undergoing hepatectomy.

NCT ID: NCT06406218 Recruiting - Clinical trials for Acute Myocardial Infarction

The Impact of Phase I Cardiac Rehabilitation on the Prognosis of AMI Patients After PCI

AID
Start date: April 24, 2024
Phase: N/A
Study type: Interventional

Previous research has confirmed that patients undergoing percutaneous coronary intervention (PCI) can benefit from cardiac rehabilitation programs. However, there is a paucity of studies on Phase I cardiac rehabilitation commenced within three days following PCI in patients with acute myocardial infarction (AMI). Consequently, the objective of the study is to demonstrate whether Phase I cardiac rehabilitation can improve the prognosis at 12 months when compared with the control group. The primary endpoint is the Seattle Angina Questionnaire (SAQ) score at 12 months for the patients. The principal hypothesis of the study is that Phase I cardiac rehabilitation will improve the long-term prognosis for AMI patients at 12 months after PCI.

NCT ID: NCT06406205 Recruiting - Lupus Nephritis Clinical Trials

A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis

Start date: December 25, 2023
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the efficacy of QL1074 compared with placebo in achieving renal response after 52 weeks of therapy in subjects with Active Lupus Nephritis.

NCT ID: NCT06406166 Recruiting - Clinical trials for Advanced Non Small Cell Lung Cancer

Lifei Xiaoji Wan in Treatment of Advanced NSCLC

Start date: June 1, 2022
Phase: N/A
Study type: Interventional

This study is to evaluate the clinical efficacy of Lifei Xiaoji Wan for advanced non-small cell lung cancer (NSCLC), establish the treatment scheme, and obtain high-quality clinical evidence.

NCT ID: NCT06406062 Not yet recruiting - Adenoma Colon Polyp Clinical Trials

Artificial Intelligence-assisted System in Colonoscopy

Start date: May 20, 2024
Phase:
Study type: Observational

In recent years, computer-aided diagnosis system based on artificial intelligence (AI) has been used in colorectal polyp detection. In recent years, computer-aided diagnosis system based on artificial intelligence (AI) has been used in colorectal polyp detection. However, whether AI-assisted can improve the adenoma-detection rate (ADR) is inconclusive. This study aims to evaluate the real-world performance of an AI system that combines polyp detection with colonoscopy quality control. This study aims to explore the clinical application value of AI-based polyp detection and quality control function by comparing the data of polyp detection rate and adenoma detection rate in multiple centers with and without AI-assisted colonoscopy in a multicenter, prospective real world study. However, whether AI-assisted can improve the adenoma-detection rate (ADR) is inconclusive. This study aims to evaluate the real-world performance of an AI system that combines polyp detection with colonoscopy quality control. This study aims to explore the clinical application value of AI-based polyp detection and quality control function by comparing the data of polyp detection rate and adenoma detection rate in multiple centers with and without AI-assisted colonoscopy in a multicenter, prospective real world study.

NCT ID: NCT06405945 Recruiting - Clinical trials for Cervical Cancer Susceptible Population Classification

Cervical Cancer Susceptible Population Classification

Start date: May 1, 2024
Phase:
Study type: Observational

Cervical cancer is the third most common lethal tumor globally, causing around a quarter million deaths annually, despite the availability of HPV vaccines. Recent Genome-wide association studies (GWAS) have identified numerous genetic markers linked to cervical cancer, including rs10175462, rs10007915, rs35721900, and rs61646675, which have been verified as being related to susceptibility to cervical cancer. However, many reports lack clarity, consistency, and validation. In this comprehensive study, we will analyze the genomic risk factors associated with cervical cancer, classify individuals into different risk categories, and explore potential biomarkers and therapeutics.

NCT ID: NCT06405815 Completed - Clinical trials for Lung Cancer, Nonsmall Cell

A Radiomic Model for Risk of Local Recurrence and DFS for T3 and T4 Non-small Cell Lung Cancer

Start date: January 1, 2021
Phase:
Study type: Observational

The investigators retrospectively collected the participants with T3 and T4, N0-2, M0 NSCLC patients resected between January 2013 to December 2021 for training and internal validation. The Clinical data, preoperative laboratory results and images were collected. High-risk margins were defined as R1 or R2 surgical margins or local recurrence during follow-up, and the investigators also collected the disease-free survival time. On the Deepwise multi-modal research platform, the images were semi-automatically segmented and expanded outward by 3mm to obtain the peritumor tissue. PyRadiomics was used to extract the radiomic features. LASSO was used to select the features and tumor radiomics model, peritumor model and combined model were built using 5-fold cross-validation. And it was further tested on the independent cohort. Discrimination was assessed by using the C-index and area under the receiver operating characteristic curve (AUC), sensibility, specificity.

NCT ID: NCT06405776 Recruiting - Colorectal Cancer Clinical Trials

Effect of Lidocaine on Postoperative Pain and Long-term Survival in Elderly Patients Undergoing Colorectal Surgery

Start date: June 5, 2023
Phase: N/A
Study type: Interventional

This study is a further observation and follow-up of the patients enrolled in the registration number NCT05920980 to further evaluate the effect of long-term infusion of lidocaine on postoperative chronic pain, long-term quality of life and survival rate in patients undergoing colorectal cancer surgery.

NCT ID: NCT06405737 Active, not recruiting - Healthy Clinical Trials

Oxytocin's Effect on the Advantageous- and Disadvantageous-inequity

Start date: January 7, 2024
Phase: N/A
Study type: Interventional

The main aim of the study is to investigate whether intranasal oxytocin modulates advantageous- and disadvantageous-inequity and whether oxytocin has similar effects on them or not.